Abstract:Background Primary cutaneous lymphomas are neoplasms of the immune system with a distinct tropism for the skin and an absence of extracutaneous manifestations at the time of diagnosis. Studies focusing on cutaneous lymphomas in children and adolescents remain scarce and often do not encompass the rare subtypes. Objectives To address this knowledge gap by describing the clinical, histological and molecular characteristics of a large group of paediatric patients affected by primary cutaneous lymphoma. We also provided the Paediatric Primary Cutaneous Lymphoma Atlas that illustrates the clinicopathological spectrum of observed presentations, in the hope of supporting other physicians in the diagnostic process. Methods Retrospective chart review of paediatric patients diagnosed with primary cutaneous lymphomas between 1980 and 2022 at the Paediatric Dermatology Unit of Fondazione IRCCS Ca′ Granda Ospedale Maggiore Policlinico, Milan. Results A total of 101 patients (58 males, 43 females) met the inclusion criteria. The most common subtypes were lymphomatoid papulosis (n = 48) and mycosis fungoides (n = 31). These were followed by primary cutaneous CD4+ small/medium T‐cell lymphoproliferative disorders (n = 7), primary cutaneous anaplastic large‐cell lymphomas (n = 5), primary cutaneous marginal zone B‐cell lymphomas (n = 3), primary cutaneous follicle centre lymphomas (n = 2), subcutaneous panniculitis‐like T‐cell lymphomas (n = 2), primary cutaneous peripheral T‐cell lymphoma not otherwise specified (n = 1), primary cutaneous precursor B‐lymphoblastic lymphoma (n = 1) and Sézary syndrome (n = 1). Clinical follow‐up data covering a median of 70.8 months (range 1–324) were available for 74 patients, of whom three died due to cutaneous lymphoma. Conclusions Our findings shed light on the peculiar aspects and long‐term outcomes of paediatric cutaneous lymphomas, particularly emphasizing their distinctive features in comparison to their adult counterparts and exploring the less common subtypes. Further larger‐scale studies are warranted to better characterize these entities and to achieve a more rapid and accurate diagnosis.

A sixteen-year single-center retrospective chart review of Spitz nevi and spitzoid neoplasms in pediatric patients

Clinical Features and Outcomes of Paediatric Spitz-type Lesions

Genetic Similarities Between Spitz Nevus and Spitzoid Melanoma in Children

The Clinical, Morphologic, and Molecular Spectrum of BRAF Fusion Spitz Tumors

Evaluation and Surgical Management of Pediatric Cutaneous Melanoma and Atypical Spitz and Non-Spitz Melanocytic Tumors (Melanocytomas): A Report From Children's Oncology Group

Restrospective reappraisal of the prognostic classification of spitzoid melanocytic neoplasms after BRAF and NRAS mutation characterisation: a single institution experience

Clinicopathological Analysis of 719 Pediatric and Adolescents’ Ocular Tumors and Tumor-Like Lesions: a Retrospective Study from 2000 to 2018 in China

Spitz Melanocytic Tumors: A Fascinating 75-Year Journey

Gene Expression Profile of Benign, Intermediate, and Malignant Spitz and Spitzoid Melanocytic Lesions

[ALK rearranged Spitz melanocytoma: a clinicopathological and molecular genetic analysis of two cases]

Paediatric cutaneous lymphomas including rare subtypes: A 40‐year experience at a tertiary referral centre

Spitz melanoma is a distinct subset of spitzoid melanoma

Role of Targeted Sequencing in Routine Diagnostics of Spitz Melanocytic Neoplasms—An Analysis of 70 Cases

Spitz tumours and mimickers

Treatment outcomes following partial shave biopsy of atypical and malignant melanocytic tumors in pediatric patients

Clinical, Morphologic, and Molecular Features of MAP3K8 Rearranged Spitz Neoplasms

“Red Spitz Tumor” on the Ear: Case Report and Review of the Literature

Pathologic Characteristics of Spitz Melanoma with MAP3K8 Fusion or Truncation in a Pediatric Cohort

Regional lymph node evaluation in pediatric conventional melanoma subtype: a single-center 10-year review

Pediatric mandibular malignancies: a comprehensive analysis of SEER data

A Retrospective Review and Comprehensive Tumour Profiling of Advanced Non-Melanomatous Cutaneous Spindle Cell Neoplasms Treated with Immune-Checkpoint Inhibitors